BioSpace News Archive

According to Vision Research Reports, the preclinical CRO market size is expected to garner around US$ 8.9 billion by 2030 and is projected to grow at a CAGR of 8.5% from 2021 to 2030.

Kinnate Biopharma Inc., a clinical-stage precision oncology company, announced that the company will participate in two upcoming in-person investor conferences.

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in complement, announced that the company will participate in the following investor conferences in June.

Opiant Pharmaceuticals, Inc. (Opiant) (NASDAQ: OPNT) today announced the filing of the first module of its New Drug Application (NDA) for OPNT003, nasal nalmefene, for the treatment of opioid overdose.

Icosavax, Inc. announced that the company will participate in the Jefferies Healthcare Conference taking place from June 8-10, 2022.

Aclaris Therapeutics, Inc. announced that Dr. Neal Walker, President and CEO of Aclaris, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 11:30 a.m. ET in New York, New York.

Atreca, Inc. announced a corporate reorganization to extend its cash runway through 2023, including a workforce reduction of more than 25%.

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that management will participate in one-on-one investor meetings and present at the 2022 Jefferies Healthcare Conference to be held June 8-10, 2022 in New York, NY.

BioAtla, Inc. announced that Jay M. Short, Ph.D., Chairman, Chief Executive Officer and co-founder, and Scott Smith, President, will provide a corporate update and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference, to be held in-person in New York, NY June 8-10, 2022.

Audiology Devices Market size is expected to reach USD 17.43 Billion in 2030 and register a revenue CAGR of 5.3% during the forecast period.